Dr. Christopher J. Pole, M.D.
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- Medical school
- Saint Louis University School of Medicine (2008)
- Years since graduation
- 18
- In the NPI registry since
- 2008
- Medicare patients seen, 2024
- 1,242
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2008Medical school: Saint Louis University School of Medicine
- 2008Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
KS license 04-35809 · MO license 2012016535
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Neosho Memorial Regional Medical Center Chanute, KS
- Fredonia Regional Hospital Fredonia, KS
Medical groups
- Murphy Watson Burr Eye Center, Inc. (9 clinicians)
- Reynolds and Anliker Eye Physicians and Surgeons LLC (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,242
- Services billed
- 4,350
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Established patient complete exam of visual system | 853 | 813 |
| Measurement of corneal curvature and depth of eye | 673 | 405 |
| Removal of cataract with insertion of prosthetic lens | 609 | 338 |
| Insertion of drug delivery implant into tear duct of eye | 578 | 322 |
| Imaging of retina | 467 | 443 |
| Established patient problem focused exam of visual system | 357 | 330 |
| New patient office or other outpatient visit, 45-59 minutes | 322 | 322 |
| Removal of recurring cataract in lens capsule using a laser | 205 | 134 |
| Imaging of optic nerve | 185 | 183 |
| Exam of visual field with extended testing | 130 | 125 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisolone Acetate Other prescribers in Overland PArk, KS | 574 |
| Ketorolac Tromethamine Other prescribers in Overland PArk, KS | 363 |
| Ofloxacin Other prescribers in Overland PArk, KS | 346 |
| Latanoprost Other prescribers in Overland PArk, KS | 288 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Overland PArk, KS | 95 |
| Lumigan (bimatoprost) Other prescribers in Overland PArk, KS | 79 |
| Timolol Maleate Other prescribers in Overland PArk, KS | 63 |
| Restasis (cyclosporine) Other prescribers in Overland PArk, KS | 51 |
| Brimonidine Tartrate-Timolol (brimonidine tartrate/timolol) Other prescribers in Overland PArk, KS | 51 |
| Erythromycin (erythromycin base) Other prescribers in Overland PArk, KS | 50 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 29 payments worth $9,651 in total to this clinician.
| Rxsight Inc | $8,691 |
|---|---|
| Alcon Vision LLC | $352 |
| Glaukos Corporation | $309 |
| Tarsus Pharmaceuticals, Inc. | $103 |
| Beaver-visitec International, Inc. | $70.95 |
| Bausch & Lomb Americas Inc. | $48.73 |
| Harrow Eye, LLC | $39.40 |
| Sight Sciences, Inc. | $19.64 |
| Consulting Fee | $8,250 |
|---|---|
| Food and Beverage | $1,401 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Rxsight Inc Nov 3, 2025 | Consulting Fee RXSIGHT CONTACT LENS; LIGHT ADJUSTABLE LENS (LAL); RXSIGHT LIGHT DELIVERY DEVICE (LDD) · OPHTHALMOLOGY | $4,000 |
| Rxsight Inc Nov 25, 2025 | Consulting Fee LIGHT ADJUSTABLE LENS (LAL); RXSIGHT CONTACT LENS; RXSIGHT INJECTOR HANDPIECE · OPHTHALMOLOGY | $3,000 |
| Rxsight Inc Jul 21, 2025 | Consulting Fee RXSIGHT CONTACT LENS; RXSIGHT INJECTOR CARTRIDGE; RXSIGHT LIGHT DELIVERY DEVICE (LDD) · OPHTHALMOLOGY | $1,250 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $103,523 in research payments for these studies, mostly to the institutions running them.
- Impact of Lumify on patients using Rocklatan eye drops to treat glaucoma
Alcon Research LLC
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.